• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    (NY: BLCO )

    19.00 +0.12 (+0.64%)
    Official Closing Price Updated: 7:00 PM EDT, Oct 4, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 218,087
    Open 19.01
    Bid (Size) 18.64 (1)
    Ask (Size) 19.51 (1)
    Prev. Close 18.88
    Today's Range 18.83 - 19.04
    52wk Range 13.16 - 21.00
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Nike Reports Weak Sales, Joins Lamb Weston And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
    Via Benzinga
    Bausch + Lomb Launches Opal™ Digital Marketplace in the United States
    From Bausch + Lomb Corporation
    Via Business Wire

    Performance

    YTD
    +12.29%
    +12.29%
    1 Month
    +16.49%
    +16.49%
    3 Month
    +29.08%
    +29.08%
    6 Month
    +15.50%
    +15.50%
    1 Year
    +10.79%
    +10.79%

    More News

    Read More
    Bausch Health: A Buyout Bid Could Be the Ticket to Unlock Value
    Via MarketBeat
    Bausch & Lomb And Edgewise Therapeutics Are Among Top 7 Mid Cap Stock Gainers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?
    Via Benzinga
    Topics Economy
    Exposures Interest Rates
    Why Bausch + Lomb Rallied Today
    Via The Motley Fool
    Apple, Amazon, Microsoft, Meta Lead The Charge As Investors Bank On Tech Cheer For Rally's Reacceleration: Week Ahead In Earnings
    Via Benzinga
    Topics Economy
    Exposures Interest Rates
    Applied Therapeutics, PowerFleet, VF Corp, Victoria's Secret And Other Big Stocks Moving Higher On Wednesday
    Via Benzinga
    Contact Lens Supplier Bausch + Lomb Eyes Sale Amid Separation Challenges As Parent Bausch Health Faces Debt Issues
    Via Benzinga
    Topics Supply Chain
    Exposures Supply Chain
    Bausch Reportedly Explores A Sale; Could Alcon, J&J Or AbbVie Buy It?
    Via Investor's Business Daily
    Alcoa, Lattice Semiconductor, Stratasys And Other Big Stocks Moving Higher On Monday
    Via Benzinga
    Tech Stocks On Track For Best Session In 5 Months Ahead Of Fed Meeting; Small Caps Target Highest Close Since January 2022: What's Driving Markets Wednesday?
    Via Benzinga
    Topics Economy
    Exposures Interest Rates
    Bausch + Lomb Announces Second-Quarter 2024 Results
    From Bausch + Lomb Corporation
    Via Business Wire
    Wall Street Remains On Track For AMD-Led Rebound Ahead Of Fed Decision, Meta Earnings: Analyst Says 'The Bull Tends To Remain' Despite Near-Time Volatility
    Via Benzinga
    Topics Economy
    Exposures Interest Rates
    Bausch + Lomb Will Release Second-Quarter 2024 Financial Results on July 31
    From Bausch + Lomb Corporation
    Via Business Wire
    Why General Dynamics Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Millions of Americans Experience Dry Eye Symptoms, Yet New National Survey Shows Sufferers Struggle to Find Relief
    From Bausch + Lomb Corporation
    Via Business Wire
    Why Is Clearside Biomedical Stock Gaining Today?
    Via Benzinga
    Bausch + Lomb Announces Presentation of New Data at the European Dry Eye Society 2024 Congress
    From Bausch + Lomb Corporation
    Via Business Wire
    Bausch + Lomb INFUSE® for Astigmatism Silicone Hydrogel Daily Disposable Contact Lenses Introduced in the United States
    From Bausch + Lomb Corporation
    Via Business Wire
    Bausch + Lomb Launches Blink™ NutriTears® Clinically Proven Nutritional Supplement for Dry Eyes in the United States
    From Bausch + Lomb Corporation
    Via Business Wire
    Bausch + Lomb Announces 2024 Annual Meeting of Shareholder Results
    From Bausch + Lomb Corporation
    Via Business Wire
    Bausch + Lomb Announces Presentation of New Scientific Data and Evaluations Featuring Consumer, Vision Care and Pharmaceutical Products at Optometry’s Meeting®
    From Bausch + Lomb Corporation
    Via Business Wire
    Bausch + Lomb Receives Health Canada Approval for enVista® Envy™* Full Visual Range Intraocular Lens
    From Bausch + Lomb Corporation
    Via Business Wire
    Do You Have Your Eye On Vision Care Stocks?
    Via Talk Markets
    American Airlines To Rally Around 59%? Here Are 10 Top Analyst Forecasts For Monday
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.